Alpha lipoic acid
Alpha lipoic acid is a dietary supplement with 36 clinical trials. Currently 3 active trials ongoing. Historical success rate of 96.4%.
Success Metrics
Based on 27 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
9
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
96.4%
27 of 28 finished
3.6%
1 ended early
3
trials recruiting
36
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Lipoic Acid Supplement for Cystine Stone
Effect of Low-Dose Versus High-Dose Alpha-Lipoic Acid on Oxidative Stress, Inflammation, and Clinical Outcomes in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Alpha Lipoic Acid to Decrease Pain and Side Effects in Concurrent Treatment of HNSCC
Alpha Lipoic Acid in Pediatrics on Hemodialysis
Photobiomodulation Therapy vs. Alpha-Lipoic Acid in Burning Mouth Syndrome Treatment
Clinical Trials (36)
Lipoic Acid Supplement for Cystine Stone
Effect of Low-Dose Versus High-Dose Alpha-Lipoic Acid on Oxidative Stress, Inflammation, and Clinical Outcomes in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Alpha Lipoic Acid to Decrease Pain and Side Effects in Concurrent Treatment of HNSCC
Alpha Lipoic Acid in Pediatrics on Hemodialysis
Photobiomodulation Therapy vs. Alpha-Lipoic Acid in Burning Mouth Syndrome Treatment
Evaluation of the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients
Prevention of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients
Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects
Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females
Assessment of Antioxidant Therapy on Oxidative Stress Biomarkers in Type 2 Diabetic Patients With Neuropathy
Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.)
Clinical Study Evaluating the Safety and Efficacy of Roflumilast in Type 2 Diabetic Patients With Diabetic Neuropathy
A Novel Role of Alpha Lipoic Acid in Comparison With Selenium in Mitochondrial Resuscitation and miRNA-126 Expression in Hemodialysis Patients
Alpha Lipoic Acid and Diabetes Mellitus: Potential Effects on Peripheral Neuropathy
Impact of Alpha-Lipoic Acid Ingestion on Glucose Tolerance in Subjects With Pre-Diabetes
Alpha Lipoic Acid in Geographic Atrophy
Impact of Lipoic Acid Use on Stroke Outcome After Reperfusion Therapy in Patients With Diabetes (IMPORTANT)
Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis
The Use of Alpha Lipoic Acid for the Treatment and Prevention of Diabetic Retinopathy
Alpha Lipoic Acid Supplementation and Metabolic Syndrome
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 36